Neuroscience News

This week, we talk with "radical behaviorist" Kim Bullock about how virtual reality technologies could serve as behavioral therapeutics to enhance psychotherapy.

The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease, but which also carry safety risks according to Knight Initiative for Brain Resilience affiliate Mike Greicius and others.

Experts at Stanford Medicine Children’s Health helped conduct clinical trials for the new therapy, which gives kids with X-linked adrenoleukodystrophy, or ALD, a functioning copy of the abnormal gene.

This week, we talk with Michelle Monje and Rob Malenka about recent findings on the role of myelin plasticity in opioid addiction.

In an analysis of more than 2 million patient records, researchers discovered that people taking angiotensin receptor blockers for high blood pressure were less likely to develop epilepsy.

Brain imaging, known as functional MRI, combined with machine learning can predict a treatment response based on one’s depression “biotype.”

To advance neuroscience research using EEG and TMS technologies, the Koret Human Neurosciences Community Lab has awarded its inaugural Human Neuroscience Pilot Grants to ten innovative research projects.

Wu Tsai Neuro affiliate Michelle Monje and team discovered that adaptive myelination, a form of brain plasticity, contributes to drug addiction. A single morphine dose in mice triggered myelination in reward-related brain circuits, reinforcing drug-seeking behavior. Blocking this myelination prevented addiction, highlighting potential new treatment strategies.

A study in mice by Wu Tsai Neuro affiliate Michelle Monje and team has found that the process of adaptive myelination, which helps the brain learn new skills, can also promote addiction to opioids.

In a new, large-scale study of sleep behavior, Wu Tsai Neuro affiliate Jamie Zeitzer and team found that night owls don’t thrive late at night.

Most Parkinson’s disease patients struggle with speech problems. New research by Stanford Medicine scientists uncovers the brain connections that could be essential to preserving speech.

Wu Tsai Neuro's multidisciplinary "Big Ideas in Neuroscience" initiative connected addiction-focused basic research, clinical application, and public policy to create a community across traditional disciplinary boundaries, deepening understanding of decision-making.

Recognizing the potential for wider application in small-animal neuroscience research, the Neurosciences Preclinical Imaging Lab (NPIL) at Wu Tsai Neuro hosted its 3rd annual symposium and named the recipients of its Pilot Grants.

This week on From Our Neurons to Yours, we talk with anesthesiologist Boris Heifets about studies that could change our understanding of the renaissance in psychedelic medicine.

Learn how a silo-busting program to probe neuropsychiatric disease was hatched over lunch with Wu Tsai Neuro affiliates Paul Nuyujukian, Karl Deisseroth, Carolyn Rodriguez, and Vivek Buch.

New research led by Wu Tsai Neuro affiliate Sergiu Pasca on Timothy syndrome may have implications beyond the rare genetic disorder — including conditions like schizophrenia. Supported by the Wu Tsai Neuro Big Ideas in Neuroscience grant program.